Form D · Biotechnology

JumpCode Genomics, Inc.

San Diego, CA · CIK 0001698131

Offering snapshot reported Aug 22, 2024 · SEC filing

Reported sold
$3.46M
Offering amount: $11.5M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 15, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 22, 2024Initial$3,458,827No comparison8SEC filing
May 9, 2023Initial$9,189,499No comparison7SEC filing
Dec 26, 2020Initial$21,012,997No comparison5SEC filing
Feb 11, 2020Initial$1,500,000No comparison1SEC filing
Sep 12, 2018Initial$3,511,275No comparison4SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-522157
Totals include amounts receivable upon the exercise of warrants. Such warrants have not yet been exercised.

Source: Form D, filed Aug 22, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Keith Brown Executive
Eugene Chen Director
Yaron Hakak Director, Executive
Dan Kidle Director
Joseph Lee Director
Kevin Li Director
Michael Liang Director
Kirk Malloy Director
Brandon Poe Executive
Joel Rotroff Director
David Michael Salter Director, Executive
Court Turner Director
Frank Witney Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10055 Barnes Canyon Rd Suite 400
San Diego, CA, 92121